Purification of triphosphorylated oligonucleotides using capture tags
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C07H-021/00
C12N-015/113
C07H-021/02
C07H-001/04
C07H-001/02
출원번호
US-0178881
(2016-06-10)
등록번호
US-9896689
(2018-02-20)
우선권정보
EP-11160032 (2011-03-28)
발명자
/ 주소
Ludwig, Janos
Goldeck, Marion
Sproat, Brian
출원인 / 주소
Rheinische Friedrich-Wilhelms-Universität Bonn
대리인 / 주소
Rothwell, Figg, Ernst & Manbeck, P.C.
인용정보
피인용 횟수 :
0인용 특허 :
34
초록
The present invention relates to a method of preparing triphosphate-modified oligonucleotides using a capture tag. The method allows the synthesis and purification of triphosphate-modified oligonucleotides in high yield and purity suitable for pharmaceutical applications.
대표청구항▼
1. A method of preparing an oligonucleotide of formula (I), wherein V1, V3 and V5 are independently selected from the group consisting of O, S and Se;V2, V4 and V6 are independently selected from the group consisting of OH, OR1, SH, SR1, F, NH2, NHR1, N(R1)2 and BH3−M+,W1 is O or S,W2 is O, S, NH or
1. A method of preparing an oligonucleotide of formula (I), wherein V1, V3 and V5 are independently selected from the group consisting of O, S and Se;V2, V4 and V6 are independently selected from the group consisting of OH, OR1, SH, SR1, F, NH2, NHR1, N(R1)2 and BH3−M+,W1 is O or S,W2 is O, S, NH or NR2,W3 is O, S, NH, NR2, CH2, CHHal or C(Hal)2,R1, R2 and R3 are selected from the group consisting of C1-6 alkyl, C2-6alkenyl, C2-6 alkynyl, C2-6 acyl and a cyclic group, each substituted or unsubstituted,or wherein two R1 may form a ring together with an N-atom bound thereto,M+is a cation,X is NH, NR3, O or S,Z represents a capture tag which is a C8-24 alkyl residue, a perfluoroalkyl entity, an azide, an alkynyl group, a chemical entity containing an amino group in an NH2—Y—XH type reagent, a chloroformate group, a lipidic residue, or a first partner of a non-covalent binding pair which has a binding constant of 10−6 l/mol or less to its complementary binding partner, wherein said first partner is selected from the group consisting of biotin, desthiobiotin, a hapten, and an antigen, and the complementary binding partner is a streptavidin, an avidin, or an antibody,Y represents a bond or a linker connecting the capture tag to X, andON represents an oligonucleotide comprising at least 4 nucleotides or nucleotide analogue building blocks,comprising the steps:(a) reacting a compound of formula (lla) with an oxidizing agent to obtain a compound of formula (llb) (b) reacting a compound of formula (llb) with a capture tag agent of formula (lll), Z—Y—XH (lll)to obtain a reaction product comprising the oligonucleotide of formula (I), and(c) contacting the reaction product of step (b) with a capture reagent capable of interacting with the capture tag, wherein the contacting takes place under conditions which allow separation of the oligonucleotide (I) from other species contained in said reaction product. 2. The method of claim 1, wherein Y is an alkylene linker, or an aralkylene linker selected from the group consisting of (i) an alkylene linker, or an aralkylene linker comprising heteroatoms or heteroatom containing groups,(ii) an alkylene linker, or an aralkylene linker comprising C═C or C≡C bonds, and(iii) an alkylene linker, or an aralkylene linker comprising both heteroatoms or heteroatom containing groups, and C═C or C≡C bonds. 3. The method of claim 2, wherein the heteroatom containing groups are selected from the group consisting of O, S, NH, C═O, and C═S. 4. The method of claim 1, wherein Y is a polyalkylene oxide linker selected from (i) a poly—C2—C6—alkylene oxide,(ii) a poly—C2—C3—alkylene oxide,(iii) a linker with a number average molecular weight in the range of 30-800 g/mol, and(iv) a linker which is [—CH2CHR4—O—]n, wherein n is 1-10, and R4 represents H or C1-6—alkyl. 5. The method of claim 1, wherein Y is —CH2—CH2—[(O—CH2CH2)]3—. 6. The method of claim 1, wherein Z is a lipidic residue selected from cholesteryl and tocopheryl. 7. The method of claim 1, wherein Z is a perfluoralkyl entity selected from a 4-(1H, 1H, 2H, 2H-perfluorodecyl)benzyl and 3-(perfluorooctyl)propyl residue. 8. The method of claim 1, wherein Z—Y—X is propargylamino. 9. The method of claim 1, wherein the capture tag and the capture reagent capable of interacting therewith are selected from: (i) a hydrophobic or fluorinated group and a chromatographic material with affinity for hydrophobic or fluorinated groups;(ii) a first partner of a non-covalent binding pair and a second partner of a non-covalent binding pair, and(iii) a first partner of a covalent binding pair and a second partner of a covalent binding pair, where the first and second partner form covalent bonds. 10. The method of claim 1, wherein the triphosphate/triphosphate analogue group is attached to the 5′-terminus of the oligonucleotide. 11. The method of claim 10, wherein the triphosphate/triphosphate analogue group is attached to the 5′-OH-group of the 5′-terminal sugar thereof. 12. The method of claim 1, further comprising the step: (d) removing the capture tag to obtain an oligonucleotide of formula (IV): wherein V1, V3, V5, V2, V4, V6, W1, W2, W3 and ON are as defined in claim 1. 13. The method of claim 1, wherein the oligonucleotide is selected from desoxyribonucleotides, ribonucleotides and oligonucleotide analogues. 14. The method of claim 1, wherein the oligonucleotide is single-stranded or double stranded. 15. The method of claim 14, wherein the oligonucleotide is double-stranded and the duplex is closed by a loop at the distal end thereof, wherein the loop comprises nucleotide and/or non-nucleotide building blocks. 16. The method of claim 14, wherein the oligonucleotide is double-stranded and the duplex is blunt-ended at the proximal end thereof. 17. Oligonucleotide of Formula (I), obtainable by a method comprising (a) reacting a compound of formula (lla) with an oxidizing agent to obtain a compound of formula (llb) (b) reacting a compound of formula (llb) with a capture tag agent of formula (lll), Z—Y—XH (lll)to obtain a reaction product comprising the oligonucleotide of formula (I), and(c) contacting the reaction product of step (b) with a capture reagent capable of interacting with the capture tag, wherein the contacting takes place under conditions which allow separation of the oligonucleotide (I) from other species contained in said reaction product,wherein V1, V3, V5, V2, V4, V6, W1, W2, W3, X, Y, Z and ON are defined as in claim 1, and wherein X, Z and Y are defined as in claim 1. 18. A kit for preparing an oligonucleotide of formula (I) wherein V1, V3, V5, V2, V4, V6, W1, W2, W3, X, Y, Z and ON are defined in claim 1, wherein the kit comprises:(a) a capture tag agent of formula (lll) Z—Y—XH (III)wherein X, Z and Y are defined as in claim 1, and(b) a capture reagent capable of interacting with the capture tag.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (34)
Ecker David J. (Carlsbad CA), Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides.
Wilfried Seifert, Compositions and methods for inhibiting cox-2 expression and treating cox-2 associated disorders by using cox-2 antisense oligonucleotides.
Agrawal Sudhir (Shrewsbury MA) Leiter Josef M. E. (Brooklyn NY) Palese Peter (Leonia NJ) Zamecnik Paul C. (Shrewsbury MA), Inhibition of influenza virus replication by oligonucleotide phosphorothioates.
Harel Bellan,Annick; Ait Si Ali,Slimane; Cabon Georget,Florence; Chauchereau,Anne; Dautry,Francois, Inhibitor oligonucleotides and their use for specific repression of a gene.
Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
Stec Wojciech J. (Lodz PLX) Grajkowski Andrzej (Lodz PLX) Uznanski Bogdan (Lodz PLX), Method of making oligonucleotides and oligonucleotide analogs using phospholanes and enantiomerically resolved phosphola.
Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
Pederson Thoru (Worcester MA) Agrawal Sudhir (Shrewsbury MA) Mayrand Sandra (Shrewsbury MA) Zamecnik Paul C. (Shrewsbury MA), Method of site-specific alteration of RNA and production of encoded polypeptides.
Stec Wojciech J. (Lodz PLX) Uznanski Bogdan (Lodz CA PLX) Bergot B. John (Redwood City CA) Hirschbein Bernard L. (San Francisco CA) Fearson Karen L. (Union City CA), Method of synthesizing sulfurized oligonucleotide analogs.
Cook, Phillip D.; Wang, Guangyi; Bruice, Thomas W.; Boyle, Nicholas A.; Leeds, Janet M.; Brooks, Jennifer L.; Prhavc, Marija; Ariza, Maria Eugenia; Fagan, Patrick C.; Jin, Yi; Rajwanshi, Vivek K.; Tucker, Kathleen D., Nucleotide mimics and their prodrugs.
Cook, Phillip D.; Wang, Guangyi; Bruice, Thomas W.; Boyle, Nicholas A.; Leeds, Janet M.; Brooks, Jennifer L.; Prhavc, Marija; Ariza, Maria Eugenia; Fagan, Patrick C.; Jin, Yi; Rajwanshi, Vivek K.; Tucker, Kathleen D., Nucleotide mimics and their prodrugs.
Eppstein Deborah A. (Los Altos CA) Fraser-Smith Elizabeth B. (Los Altos CA) Matthews Thomas R. (Los Gatos CA), Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.